Tuberculosis treatment monitoring and outcome measures: new interest and new strategies
Despite the advent of new diagnostics, drugs and regimens, tuberculosis (TB) remains a
global public health threat. A significant challenge for TB control efforts has been the …
global public health threat. A significant challenge for TB control efforts has been the …
Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV
S Bjerrum, I Schiller, N Dendukuri… - Cochrane Database …, 2019 - cochranelibrary.com
Background The lateral flow urine lipoarabinomannan (LF‐LAM) assay Alere Determine™
TB LAM Ag is recommended by the World Health Organization (WHO) to help detect active …
TB LAM Ag is recommended by the World Health Organization (WHO) to help detect active …
Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic …
Background HIV-associated tuberculosis is difficult to diagnose and results in high mortality.
Frequent extra-pulmonary presentation, inability to obtain sputum, and paucibacillary …
Frequent extra-pulmonary presentation, inability to obtain sputum, and paucibacillary …
Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV‐positive adults
Background Rapid detection of tuberculosis (TB) among people living with human
immunodeficiency virus (HIV) is a global health priority. HIV‐associated TB may have …
immunodeficiency virus (HIV) is a global health priority. HIV‐associated TB may have …
[HTML][HTML] Point of care diagnostics for tuberculosis
The goals of the End TB strategy, which aims to achieve a 90% reduction in tuberculosis
(TB) incidence and a 95% reduction in TB mortality by 2035, will not be achieved without …
(TB) incidence and a 95% reduction in TB mortality by 2035, will not be achieved without …
Immune biomarkers for diagnosis and treatment monitoring of tuberculosis: current developments and future prospects
Tuberculosis (TB) treatment monitoring is paramount to clinical decision-making and the
host biomarkers appears to play a significant role. The currently available diagnostic …
host biomarkers appears to play a significant role. The currently available diagnostic …
Detection of lipoarabinomannan (LAM) in urine is indicative of disseminated TB with renal involvement in patients living with HIV and advanced immunodeficiency …
TB is the leading cause of HIV/AIDS-related deaths globally. New diagnostic tools are
urgently needed to avert deaths from undiagnosed HIV-associated TB. Although simple …
urgently needed to avert deaths from undiagnosed HIV-associated TB. Although simple …
Biomarkers that correlate with active pulmonary tuberculosis treatment response: a systematic review and meta-analysis
AJ Zimmer, F Lainati, N Aguilera Vasquez… - Journal of clinical …, 2022 - journals.asm.org
Current WHO recommendations for monitoring treatment response in adult pulmonary
tuberculosis (TB) are sputum smear microscopy and/or culture conversion at the end of the …
tuberculosis (TB) are sputum smear microscopy and/or culture conversion at the end of the …
Detection of lipoarabinomannan (LAM) in urine is an independent predictor of mortality risk in patients receiving treatment for HIV-associated tuberculosis in sub …
Background Simple immune capture assays that detect mycobacterial lipoarabinomannan
(LAM) antigen in urine are promising new tools for the diagnosis of HIV-associated …
(LAM) antigen in urine are promising new tools for the diagnosis of HIV-associated …
New insights into biomarkers for evaluating therapy efficacy in pulmonary tuberculosis: a narrative review
F Zhang, F Zhang, Y Dong, L Li, Y Pang - Infectious Diseases and Therapy, 2023 - Springer
Evaluating therapy efficacy is crucial for patients with tuberculosis (TB), especially those with
drug-resistant tuberculosis (DR-TB). The World Health Organization currently recommends …
drug-resistant tuberculosis (DR-TB). The World Health Organization currently recommends …